OBJECTIVE: Susceptibility of fat mass and obesity-associated (FTO) gene polymorphisms to obesity has been reported in various populations. Polymorphisms in the melanocortin 4 receptor (MC4R) gene were recently explored as another susceptible locus. However, prognostic significance of these genetic variations has not been fully elucidated. Here, we investigated the involvement of FTO rs9939609 and MC4R rs17782313 polymorphisms in the development of obesity. Association with type 2 diabetes mellitus (T2DM) was also investigated. SUBJECTS: We analyzed 2806 community-dwelling middle-aged to elderly subjects (61+/-14 years). Clinical parameters were obtained from the subjects' personal health records, evaluated at their annual medical check-up. RESULTS: FTO genotype was significantly associated with current body mass index (BMI; TT 23.2+/-3.2, TA 23.7+/-3.2, AA 24.4+/-3.2 kg m(-2), P=2.5 x 10(-6)) and frequency of obesity (26.6, 32.0, 43.0% respectively, P=2.0 x 10(-4)). Age- and sex-adjusted odds ratio for obesity was 1.30 (P=0.004) in TA and 2.07 (P=0.002) in AA genotype. During the 9.4 years comprising the follow-up period, 214 new cases of obesity were diagnosed among 1718 subjects whose retrospective data were available. A allele frequency of the FTO genotype was significantly higher in subjects who developed obesity (22.2, 15.8%, P=0.001), Age-, sex- and initial BMI-adjusted odds ratio for the development of obesity was 1.46 (95% confidence interval, 1.04-2.04) (P=0.031). However, association studies and meta-analysis of T2DM did not actively support the involvement of FTO genotype. No significant differences were observed between the MC4R genotype and BMI (P=0.015), and the frequency of obesity (P=0.284). CONCLUSION: FTO genotype is an independent risk factor for future development of obesity.
OBJECTIVE: Susceptibility of fat mass and obesity-associated (FTO) gene polymorphisms to obesity has been reported in various populations. Polymorphisms in the melanocortin 4 receptor (MC4R) gene were recently explored as another susceptible locus. However, prognostic significance of these genetic variations has not been fully elucidated. Here, we investigated the involvement of FTOrs9939609 and MC4Rrs17782313 polymorphisms in the development of obesity. Association with type 2 diabetes mellitus (T2DM) was also investigated. SUBJECTS: We analyzed 2806 community-dwelling middle-aged to elderly subjects (61+/-14 years). Clinical parameters were obtained from the subjects' personal health records, evaluated at their annual medical check-up. RESULTS:FTO genotype was significantly associated with current body mass index (BMI; TT 23.2+/-3.2, TA 23.7+/-3.2, AA 24.4+/-3.2 kg m(-2), P=2.5 x 10(-6)) and frequency of obesity (26.6, 32.0, 43.0% respectively, P=2.0 x 10(-4)). Age- and sex-adjusted odds ratio for obesity was 1.30 (P=0.004) in TA and 2.07 (P=0.002) in AA genotype. During the 9.4 years comprising the follow-up period, 214 new cases of obesity were diagnosed among 1718 subjects whose retrospective data were available. A allele frequency of the FTO genotype was significantly higher in subjects who developed obesity (22.2, 15.8%, P=0.001), Age-, sex- and initial BMI-adjusted odds ratio for the development of obesity was 1.46 (95% confidence interval, 1.04-2.04) (P=0.031). However, association studies and meta-analysis of T2DM did not actively support the involvement of FTO genotype. No significant differences were observed between the MC4R genotype and BMI (P=0.015), and the frequency of obesity (P=0.284). CONCLUSION:FTO genotype is an independent risk factor for future development of obesity.
Authors: S D Rees; M Islam; M Z I Hydrie; B Chaudhary; S Bellary; S Hashmi; J P O'Hare; S Kumar; D K Sanghera; N Chaturvedi; A H Barnett; A S Shera; M N Weedon; A Basit; T M Frayling; M A Kelly; T H Jafar Journal: Diabet Med Date: 2011-06 Impact factor: 4.359
Authors: H Li; T O Kilpeläinen; C Liu; J Zhu; Y Liu; C Hu; Z Yang; W Zhang; W Bao; S Cha; Y Wu; T Yang; A Sekine; B Y Choi; C S Yajnik; D Zhou; F Takeuchi; K Yamamoto; J C Chan; K R Mani; L F Been; M Imamura; E Nakashima; N Lee; T Fujisawa; S Karasawa; W Wen; C V Joglekar; W Lu; Y Chang; Y Xiang; Y Gao; S Liu; Y Song; S H Kwak; H D Shin; K S Park; C H D Fall; J Y Kim; P C Sham; K S L Lam; W Zheng; X Shu; H Deng; H Ikegami; G V Krishnaveni; D K Sanghera; L Chuang; L Liu; R Hu; Y Kim; M Daimon; K Hotta; W Jia; J S Kooner; J C Chambers; G R Chandak; R C Ma; S Maeda; R Dorajoo; M Yokota; R Takayanagi; N Kato; X Lin; R J F Loos Journal: Diabetologia Date: 2011-11-23 Impact factor: 10.122
Authors: Carolina Ortega-Azorín; Jose V Sorlí; Eva M Asensio; Oscar Coltell; Miguel Ángel Martínez-González; Jordi Salas-Salvadó; Maria-Isabel Covas; Fernando Arós; José Lapetra; Lluís Serra-Majem; Enrique Gómez-Gracia; Miquel Fiol; Guillermo Sáez-Tormo; Xavier Pintó; Miguel Angel Muñoz; Emilio Ros; Jose M Ordovás; Ramon Estruch; Dolores Corella Journal: Cardiovasc Diabetol Date: 2012-11-06 Impact factor: 9.951